RBR-8bdqzd招募中未知
eonatal Screening, Mapping of the TP53 R337H mutation prevalence per municipality, Cancer history, socioeconomic profile and molecular alterations associated with tumors in the families
Associação Hospitalar de Proteção à Infância Dr Raul Carneiro0 个研究点开始时间: 2018年8月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1D 至 120Y（—）
入选标准
- •Newborn positive for mutation TP53 R337H; relatives of the positive newborn on the parental side who inherited the TP53 R337H mutation; both genders; age between 1 day and 120 years.
排除标准
- •Relatives of the parental side who did not inherit the mutation TP53 R337H.
研究者
相似试验
招募中
不适用
Setting the stage for newborn screening and gene therapy: a disease-specific retrospective survey of FHL2 and 3Familial Hemophagocytic Lymphohistiocytosis 2/3DRKS00028493niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)im Zentrum für Translationale Zellforschung200
Unknown
不适用
Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau TestOvarian CancerNCT04812938Azienda Ospedaliera San Giovanni Battista190
招募中
Unknown
Antenatal cytomegalovirus (CMV) screening pilot studyMaternal primary infection with cytomegalovirusReproductive Health and Childbirth - Antenatal careACTRN12623000710628niversity of Melbourne70
尚未招募
不适用
The study of surveillance in breast cancer with germline TP53 mutatioJPRN-UMIN000042155Faculty of medicine, University of Fukui10
已完成
不适用
Reducing False Positives in Prenatal ScreeningPregnancyNCT03375359University Hospital Tuebingen1,127